Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Empagliflozin Tablets

Approval Number

国药准字H20243457

Company国药集团容生制药有限公司

Registration Date

April 7, 2024

Drug Information

Generic Name

恩格列净片

Dosage Form

片剂

Strength

25mg

Drug Type

化学药品

Registration Date

April 7, 2024

Company Information

Applicant Company

Company Name国药集团容生制药有限公司

Company Address

河南省焦作市武陟县迎宾大道686号

Manufacturing Company

Company Name国药集团容生制药有限公司

Company Address

河南省武陟县东环路南段

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy